Sona Nanotech (CSE:SONA)- CEO, David Regan - The Market Herald Canada

" Sona Nanotech (CSE:SONA) shares plunge on FDA ruling

Skittish investors are abandoning shares in Sona Nanotech (SONA) today, after its COVID-19 antigen test application was downgraded by the US FDA.
CloudMD Software & Services Inc., - CEO, Dr Essam Hamza - The Market Herald Canada

" CloudMD (TSXV:DOC) expands footprint through iMD Health Global acquisition

Telehealth provider CloudMD (DOC) is set to acquire digital healthcare platform iMD Health Global in a cash-share deal valued at C$10 million.
Datametrex sends COVID-19 kits to Latin America

" Microbix Biosystems (TSX:MBX) receives Australian registration for REDx Controls

Microbix Biosystems (MBX) has received Australian Therapeutic Goods Administration (TGA) approval for its COVID-19 quality assessment products.
DIAGNOS - President, André Larente - The Market Herald Canada

" DIAGNOS (TSXV:ADK) accepts $2M from Quebec government

Medical technology company, DIAGNOS (ADK) has received an interest-free loan of up to C$2 million from the government of Quebec.
Empower Clinics expands testing as COVID-19 spreads in Arizona

" Therma Bright (TSXV:THRM) identifies new polypeptides in race for COVID-19 test

Medical technologists Therma Bright (THRM) leapt up 17 per cent today, after identifying series of polypeptides for the detection of COVID-19.
Champignon Brands Inc. - CEO, Roger McIntyre - The Market Herald Canada

" Champignon Brands (CSE:SHRM) to offer esketamine as a treatment for MDD

Champignon Brands (SHRM) is set to offer esketamine as a treatment for adults with major depressive disorder (MDD) at its clinic in Ontario.
Sona Nanotech Inc. - President & CEO, Darren Rowles - The Market Herald Canada

" Sona Nanotech (CSE:SONA) reveals strong clinical study results for COVID-19 test

Sona Nanotech (SONA) has revealed promising clinical evaluation study results for its rapid detection COVID-19 antigen test.
Empower Clinics expands testing as COVID-19 spreads in Arizona

" Ceapro’s (TSXV:CZO) COVID-19 therapy project hits first milestone

Biotechnology company, Ceapro (CZO) has successfully achieved the first milestone in developing an inhalable COVID-19 therapeutic.
Grant Ewing appointed as CEO of Blue Star Gold (TSXV:BAU)

" SQI Diagnostics (TSXV:SQD) names its new CEO

SQI Diagnostics (SQD) has appointed Robert L Chioini to the role of Chief Executive Officer.
Intema Solutions shares jump 50pc on $1.5M deal with Vida Life AI

" Microbix Biosystems (TSX:MBX) drop 20pc on Q2 results

Microbix Biosystems (MBX) has unveiled its second quarter report, which shows a seven per cent decrease in revenue against 2019’s same quarter.